Strattera
The dangerous drug attorneys at the Law Offices of Gregory Krasovsky can provide legal advice and representation to individuals and families considering pursuing a Strattera lawsuit. In order for a plaintiff to secure a maximum settlement in litigation of a Strattera claim, regardless of whether in an individual lawsuit or in a class action lawsuit, it is crucial that the law firm representing you have a competent and experienced team of Strattera lawyers to guide you through all of the legal hurdles as well as direct you to sufficient funding (litigation funding or legal finance) to cover pharmaceutical litigation costs. Contact a Strattera attorney today to schedule a free consultation and take your first step to obtaining compensation for losses caused by Stattera side effects.
Strattera, which is generically known as Atomoxetine, was approved by the US Food and Drug Administration (FDA) in 2002 to be used as a treatment for Attention Defecit Hyperactivity Disorder (ADHD) and Attention Defecit Disorder (ADD), which has since been relabeled as ADHD. Strattera, unlike the amphetamine-resembling Adderall and Ritalin, is a selective norepinephrne uptake inhibitor (NRI). This means that Strattera has less potential for abuse than does Adderall, Concerta, Dexedrine, and Ritalin. Strattera is marketed by Eli Lilly, and it is required to have a black box warning because of serious Strattera adverse effects, namely liver damage and suicidal tendencies.
In September, 2005, the FDA issued a health advisory regarding Strattera after Eli Lilly submitted results from a clinical trial. These results showed that teenagers and youths have an increased tendency to harbor suicidal thoughts as a result of taking Strattera. Although no suicides have been yet reported, there have been instances of attempted suicide stemming from the use of Strattera. Strattera was initially developed as an antidepressant, but was found to have no positive effects on depression, so Eli Lilly decided to market it to concerned parents who would be easily convinced to feed mind-altering substances to their children.
Aside of the increased tendency to commit suicide, Strattera can also cause serious liver damage. In 2004, the FDA mandated that Strattera have a black box warning regarding its ability to cause serious liver damage and jaundice. Doctors were advised to stop prescribing Strattera to patients who exhibit symptoms of the aforementioned conditions. Indeed, Strattera-induced liver damage can cause liver failure, which can then result in death or a liver transplant surgery.
Strattera adverse effects include, but are not limited to, the following:
- Liver Damage
- Liver Failure
- Sexual Problems
- Decreased Libido
- Weight Changes
- Obsessive Compulsive Behavior
- Suicidal Tendencies
- Suicidal Ideation
- Suicide
- Palpitations
- Suicidal Thoughts
- Abnormal Thought Patterns
- Psychosis
- Self-mutilation
- Self-Destructive Behavior
- Increases in Heart Rate
- High Blood Pressure
- Heart Attack
- Overdose
In England, Strattera is on the Black Triangle List of drugs, which includes drugs under heavy surveillance for serious adverse reactions. Studies there have noted that there have been more than 10,000 reports of adverse psychiatric reactions to Strattera that Eli Lilly knows of. There is a good chance that there are more that have simply gone unreported.
If you or a loved one has been seriously injured as a result of taking Strattera, you might be eligible for compensation, which a Strattera law firm can help you secure. Contact one of our unsafe drug lawyers today to schedule a free and confidential case consultation.